American Journal of Epidemiology Vol. 144, No. 1: 83-97
Copyright © 1996 by The Johns Hopkins University School of Hygiene and Public Health
other |
Estimability and Interpretation of Vaccine Efficacy Using Frailty Mixing Models
1Department of Biostatistics, Rollins School of Public Health, Emory University Atlanta, GA
2Escola Nacional de SaÚde PÚblica Fundàç
o Oswaldo Cruz, Rio de Janeiro, Brazil
Reprint requests to Department of Biostatistics, Rollins School of Public Health, Emory University, 1518 Clifton Road NE, Atlanta, GA 30322.
The authors consider estimability and interpretation of vaccine efficacy based on time to event data, allowing that some of the population might have a very low probability of acquiring disease, and the rest have partial, possibly continuously distributed, susceptibility. The efficacy parameters of interest in the fraitty mixing model include the fraction highly unlikely to acquire the infection or disease due to the vaccine, the degree of partial protection in those still susceptible, and the average protection or summary measure of efficacy under heterogeneity. The efficacy estimates can still be usefully interpreted when the heterogeneity results from heterogeneity in contact patterns, contact rates, or infectiousness of the contacts, as long as these are equal in the vaccinated and unvaccinated groups. A likelihood-based method allows estimation of the efficacy parameters of interest from grouped time to event data. Simulated vaccine studies assuming different levels and distributions of efficacy demonstrate that ignoring heterogeneity in susceptibility or exposure to infection generally results in underestimation of vaccine efficacy as well as incorrect interpretation of the estimates. The approach is also applicable to other covariates affecting susceptibility or exposure to infection in infectious diseases. Exploitation of the dependent happening structure of infectious diseases to obtain a shape for the baseline hazard may help identifiability. The authors recommend fitting several models to time to event data in vaccine studies. Am J Epidemiol 1996; 144: 83–97.
attributable risk; inference; randomization; study design; survival analysis; vaccines
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Valim, M. Mezzetti, J. Maguire, M. Urdaneta, and D. Wypij Estimation of vaccine efficacy in a repeated measures study under heterogeneity of exposure or susceptibility to infection Phil Trans R Soc A, July 13, 2008; 366(1874): 2347 - 2360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ben-Ami, R. R Regoes, and D. Ebert A quantitative test of the relationship between parasite dose and infection probability across different host-parasite combinations Proc R Soc B, April 7, 2008; 275(1636): 853 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. SMITH, G. F. KILLEEN, N. MAIRE, A. ROSS, L. MOLINEAUX, F. TEDIOSI, G. HUTTON, J. UTZINGER, K. DIETZ, and M. TANNER MATHEMATICAL MODELING OF THE IMPACT OF MALARIA VACCINES ON THE CLINICAL EPIDEMIOLOGY AND NATURAL HISTORY OF PLASMODIUM FALCIPARUM MALARIA: OVERVIEW. Am J Trop Med Hyg, August 1, 2006; 75(2_suppl): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. MAIRE, J. J. APONTE, A. ROSS, R. THOMPSON, P. ALONSO, J. UTZINGER, M. TANNER, and T. SMITH MODELING A FIELD TRIAL OF THE RTS,S/AS02A MALARIA VACCINE. Am J Trop Med Hyg, August 1, 2006; 75(2_suppl): 104 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G P Garnett, G Dubin, M Slaoui, and T Darcis The potential epidemiological impact of a genital herpes vaccine for women Sex Transm Inf, February 1, 2004; 80(1): 24 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Adams, D. C. Barth-Jones, S. E. Chick, and J. S. Koopman Simulations to Evaluate HIV Vaccine Trial Designs SIMULATION, October 1, 1998; 71(4): 228 - 241. [Abstract] [PDF]
|
|